HealthUnited States1 sourcesNeutral

Stopping GLP-1 Drugs Can Quickly Erase Cardiovascular Benefits

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide -- even temporarily -- elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

washington university in st. louis

via Newswise

March 18, 2026 | 4:00 PM UTCUpdated 18h ago

Share Read original

Read the full article at Newswise →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Newswise

NewsDataUS

Comments

0 comments

Be respectful and constructive.

Loading comments...

Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical

Health

Treasuries Close Lower After Recovery Attempt Falters

Unknown-3h ago-1 sources

Health

‘Existential crisis’: Warning to federal Libs

Joseph Olbrycht-4h ago-1 sources

Health

How Robert F. Kennedy Jr.’s Vaccine Agenda Risks a Resurgence of Deadly Childhood Plagues

Patricia Callahan-12h ago-1 sources

Stopping GLP-1 Drugs Can Quickly Erase Cardiovascular Benefits

Source Verification

Comments

Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical

Heart benefits fade after stopping GLP-1 medications

Related Articles

Treasuries Close Lower After Recovery Attempt Falters

‘Existential crisis’: Warning to federal Libs

How Robert F. Kennedy Jr.’s Vaccine Agenda Risks a Resurgence of Deadly Childhood Plagues